Evidence map›Paper›PMID 41625090›Full record

ArticleSurgical neurology international2025

Endoscopic transorbital approach to managing indirect carotid cavernous fistula: A novel technique.

Desiree Ka-Ka Wong, Norren Nok Lun Chan, Ben Chat Fong Ng, Calvin Hoi Kwan Mak

Abstract readCase Reports
In one paragraph

Article in Surgical neurology international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Desiree Ka-Ka WongDepartment of Neurosurgery, Queen Elizabeth Hospital, Hong Kong, China.
Norren Nok Lun ChanDepartment of Neurosurgery, Queen Elizabeth Hospital, Hong Kong, China.
Ben Chat Fong NgDepartment of Neurosurgery, Queen Elizabeth Hospital, Hong Kong, China.
Calvin Hoi Kwan MakDepartment of Neurosurgery, Queen Elizabeth Hospital, Hong Kong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Carotid cavernous fistula (CCF) is a rare vascular shunt between the carotid artery and the cavernous sinus, leading to venous hypertension and occasionally cortical venous reflux. It is primarily treated with endovascular therapy. However, transvenous or transarterial endovascular access may be difficult in some cases and may fail to obliterate the fistula. We describe the first case of utilizing the endoscopic transorbital approach (ETOA) to directly obliterating the CCF. Case Description: A 65-year-old man presented with the left eye blurring of vision for 2 months. He was diagnosed with the left Barrow type D indirect CCF with cortical venous reflux on digital subtraction angiogram. Primary transvenous embolization failed due to thrombosed venous access. Thus, we employed ETOA through a lid crease incision, lateral orbitotomy, and drilling of the sphenoid wing to access the cavernous sinus. Direct cannulation of the cavernous sinus was attempted. Ultimately, we injected hemostatic agents including Floseal to directly obliterate the CCF. Postoperative and follow-up digital subtraction angiogram showed complete obliteration. This is the first case of endoscopic-assisted transorbital approach to direct obliteration of a CCF. This approach allows for a smaller wound, less morbidity for complex cases with difficult venous access, with potential for complete obliteration. Conclusion: We illustrate the novel use of ETOA to direct obliteration of a complex CCF.

Indexed as

Carotid cavernous fistulaEndoscopic transorbital approachMinimally invasiveNeuroendoscopyTransorbital

Identifiers

PMID41625090
PMCPMC12860290

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.